TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global H1N1 Vaccines Market Research Report 2023

Global H1N1 Vaccines Market Research Report 2023

  • Category:Life Sciences
  • Published on : 26 December 2022
  • Pages :99
  • Formats:
  • Report Code:SMR-7520487
OfferClick for best price

Best Price: $2320

H1N1 Vaccines Market Size, Share 2022


Market Analysis and Insights: Global H1N1 Vaccines Market

The global H1N1 Vaccines market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global H1N1 Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global H1N1 Vaccines market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global H1N1 Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global H1N1 Vaccines market.

Global H1N1 Vaccines Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Intramuscular Vaccines

Intranasal Vaccines

Intradermal Vaccines

Segment by Application

Influenza

Meningococcal

Cervical Cancer

Pneumococcal

Hepatitis

Measles

Mumps

Rubella

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Abbott

Baxter International

Sanofi

GSK

Pfizer

Mitsubishi Tanabe Pharma

Hualan Biological Engineering

Cipla

Merck

Sinovac Biotech

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes H1N1 Vaccines product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of H1N1 Vaccines, with price, sales, revenue, and global market share of H1N1 Vaccines from 2019 to 2022.

Chapter 3, the H1N1 Vaccines competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the H1N1 Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the H1N1 Vaccines market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of H1N1 Vaccines.

Chapter 13, 14, and 15, to describe H1N1 Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 H1N1 Vaccines Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global H1N1 Vaccines Market Research Report 2023
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 99 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 H1N1 Vaccines Market Overview
1.1 Product Overview and Scope of H1N1 Vaccines
1.2 H1N1 Vaccines Segment by Type
1.2.1 Global H1N1 Vaccines Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Intramuscular Vaccines
1.2.3 Intranasal Vaccines
1.2.4 Intradermal Vaccines
1.3 H1N1 Vaccines Segment by Application
1.3.1 Global H1N1 Vaccines Sales Comparison by Application: (2023-2030)
1.3.2 Influenza
1.3.3 Meningococcal
1.3.4 Cervical Cancer
1.3.5 Pneumococcal
1.3.6 Hepatitis
1.3.7 Measles
1.3.8 Mumps
1.3.9 Rubella
1.3.10 Others
1.4 Global H1N1 Vaccines Market Size Estimates and Forecasts
1.4.1 Global H1N1 Vaccines Revenue 2018-2030
1.4.2 Global H1N1 Vaccines Sales 2018-2030
1.4.3 H1N1 Vaccines Market Size by Region: 2018 Versus 2022 Versus 2030
2 H1N1 Vaccines Market Competition by Manufacturers
2.1 Global H1N1 Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global H1N1 Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global H1N1 Vaccines Average Price by Manufacturers (2018-2023)
2.4 Manufacturers H1N1 Vaccines Manufacturing Sites, Area Served, Product Type
2.5 H1N1 Vaccines Market Competitive Situation and Trends
2.5.1 H1N1 Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest H1N1 Vaccines Players Market Share by Revenue
2.5.3 Global H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 H1N1 Vaccines Retrospective Market Scenario by Region
3.1 Global H1N1 Vaccines Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global H1N1 Vaccines Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America H1N1 Vaccines Market Facts & Figures by Country
3.3.1 North America H1N1 Vaccines Sales by Country
3.3.2 North America H1N1 Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe H1N1 Vaccines Market Facts & Figures by Country
3.4.1 Europe H1N1 Vaccines Sales by Country
3.4.2 Europe H1N1 Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific H1N1 Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific H1N1 Vaccines Sales by Region
3.5.2 Asia Pacific H1N1 Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America H1N1 Vaccines Market Facts & Figures by Country
3.6.1 Latin America H1N1 Vaccines Sales by Country
3.6.2 Latin America H1N1 Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa H1N1 Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa H1N1 Vaccines Sales by Country
3.7.2 Middle East and Africa H1N1 Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global H1N1 Vaccines Historic Market Analysis by Type
4.1 Global H1N1 Vaccines Sales Market Share by Type (2018-2023)
4.2 Global H1N1 Vaccines Revenue Market Share by Type (2018-2023)
4.3 Global H1N1 Vaccines Price by Type (2018-2023)
5 Global H1N1 Vaccines Historic Market Analysis by Application
5.1 Global H1N1 Vaccines Sales Market Share by Application (2018-2023)
5.2 Global H1N1 Vaccines Revenue Market Share by Application (2018-2023)
5.3 Global H1N1 Vaccines Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott H1N1 Vaccines Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Baxter International
6.2.1 Baxter International Corporation Information
6.2.2 Baxter International Description and Business Overview
6.2.3 Baxter International H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter International H1N1 Vaccines Product Portfolio
6.2.5 Baxter International Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi H1N1 Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK H1N1 Vaccines Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pfizer H1N1 Vaccines Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Mitsubishi Tanabe Pharma
6.6.1 Mitsubishi Tanabe Pharma Corporation Information
6.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Product Portfolio
6.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.7 Hualan Biological Engineering
6.6.1 Hualan Biological Engineering Corporation Information
6.6.2 Hualan Biological Engineering Description and Business Overview
6.6.3 Hualan Biological Engineering H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hualan Biological Engineering H1N1 Vaccines Product Portfolio
6.7.5 Hualan Biological Engineering Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Corporation Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cipla H1N1 Vaccines Product Portfolio
6.8.5 Cipla Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Merck H1N1 Vaccines Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Sinovac Biotech
6.10.1 Sinovac Biotech Corporation Information
6.10.2 Sinovac Biotech Description and Business Overview
6.10.3 Sinovac Biotech H1N1 Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Sinovac Biotech H1N1 Vaccines Product Portfolio
6.10.5 Sinovac Biotech Recent Developments/Updates
7 H1N1 Vaccines Manufacturing Cost Analysis
7.1 H1N1 Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of H1N1 Vaccines
7.4 H1N1 Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 H1N1 Vaccines Distributors List
8.3 H1N1 Vaccines Customers
9 H1N1 Vaccines Market Dynamics
9.1 H1N1 Vaccines Industry Trends
9.2 H1N1 Vaccines Market Drivers
9.3 H1N1 Vaccines Market Challenges
9.4 H1N1 Vaccines Market Restraints
10 Global Market Forecast
10.1 H1N1 Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of H1N1 Vaccines by Type (2023-2030)
10.1.2 Global Forecasted Revenue of H1N1 Vaccines by Type (2023-2030)
10.2 H1N1 Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of H1N1 Vaccines by Application (2023-2030)
10.2.2 Global Forecasted Revenue of H1N1 Vaccines by Application (2023-2030)
10.3 H1N1 Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of H1N1 Vaccines by Region (2023-2030)
10.3.2 Global Forecasted Revenue of H1N1 Vaccines by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global H1N1 Vaccines Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global H1N1 Vaccines Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global H1N1 Vaccines Market Size by Region (US$ Million) (2018 VS 2022 VS 2030)
Table 4. Global H1N1 Vaccines Market Competitive Situation by Manufacturers in 2022
Table 5. Global H1N1 Vaccines Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global H1N1 Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 7. Global H1N1 Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global H1N1 Vaccines Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market H1N1 Vaccines Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers H1N1 Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers H1N1 Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global H1N1 Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H1N1 Vaccines as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global H1N1 Vaccines Sales by Region (2018-2023) & (K Units)
Table 16. Global H1N1 Vaccines Sales Market Share by Region (2018-2023)
Table 17. Global H1N1 Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global H1N1 Vaccines Revenue Market Share by Region (2018-2023)
Table 19. North America H1N1 Vaccines Sales by Country (2018-2023) & (K Units)
Table 20. North America H1N1 Vaccines Sales Market Share by Country (2018-2023)
Table 21. North America H1N1 Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America H1N1 Vaccines Revenue Market Share by Country (2018-2023)
Table 23. Europe H1N1 Vaccines Sales by Country (2018-2023) & (K Units)
Table 24. Europe H1N1 Vaccines Sales Market Share by Country (2018-2023)
Table 25. Europe H1N1 Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe H1N1 Vaccines Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific H1N1 Vaccines Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific H1N1 Vaccines Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific H1N1 Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific H1N1 Vaccines Revenue Market Share by Region (2018-2023)
Table 31. Latin America H1N1 Vaccines Sales by Country (2018-2023) & (K Units)
Table 32. Latin America H1N1 Vaccines Sales Market Share by Country (2018-2023)
Table 33. Latin America H1N1 Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America H1N1 Vaccines Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa H1N1 Vaccines Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa H1N1 Vaccines Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa H1N1 Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa H1N1 Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Global H1N1 Vaccines Sales by Type (2018-2023) & (K Units)
Table 40. Global H1N1 Vaccines Sales Market Share by Type (2018-2023)
Table 41. Global H1N1 Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global H1N1 Vaccines Revenue Share by Type (2018-2023)
Table 43. Global H1N1 Vaccines Price by Type (2018-2023) & (USD/Unit)
Table 44. Global H1N1 Vaccines Sales (K Units) by Application (2018-2023)
Table 45. Global H1N1 Vaccines Sales Market Share by Application (2018-2023)
Table 46. Global H1N1 Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global H1N1 Vaccines Revenue Share by Application (2018-2023)
Table 48. Global H1N1 Vaccines Price by Application (2018-2023) & (USD/Unit)
Table 49. Abbott Corporation Information
Table 50. Abbott Description and Business Overview
Table 51. Abbott H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Abbott H1N1 Vaccines Product
Table 53. Abbott Recent Developments/Updates
Table 54. Baxter International Corporation Information
Table 55. Baxter International Description and Business Overview
Table 56. Baxter International H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Baxter International H1N1 Vaccines Product
Table 58. Baxter International Recent Developments/Updates
Table 59. Sanofi Corporation Information
Table 60. Sanofi Description and Business Overview
Table 61. Sanofi H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Sanofi H1N1 Vaccines Product
Table 63. Sanofi Recent Developments/Updates
Table 64. GSK Corporation Information
Table 65. GSK Description and Business Overview
Table 66. GSK H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. GSK H1N1 Vaccines Product
Table 68. GSK Recent Developments/Updates
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Business Overview
Table 71. Pfizer H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. Pfizer H1N1 Vaccines Product
Table 73. Pfizer Recent Developments/Updates
Table 74. Mitsubishi Tanabe Pharma Corporation Information
Table 75. Mitsubishi Tanabe Pharma Description and Business Overview
Table 76. Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Mitsubishi Tanabe Pharma H1N1 Vaccines Product
Table 78. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 79. Hualan Biological Engineering Corporation Information
Table 80. Hualan Biological Engineering Description and Business Overview
Table 81. Hualan Biological Engineering H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Hualan Biological Engineering H1N1 Vaccines Product
Table 83. Hualan Biological Engineering Recent Developments/Updates
Table 84. Cipla Corporation Information
Table 85. Cipla Description and Business Overview
Table 86. Cipla H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Cipla H1N1 Vaccines Product
Table 88. Cipla Recent Developments/Updates
Table 89. Merck Corporation Information
Table 90. Merck Description and Business Overview
Table 91. Merck H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Merck H1N1 Vaccines Product
Table 93. Merck Recent Developments/Updates
Table 94. Sinovac Biotech Corporation Information
Table 95. Sinovac Biotech Description and Business Overview
Table 96. Sinovac Biotech H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Sinovac Biotech H1N1 Vaccines Product
Table 98. Sinovac Biotech Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. H1N1 Vaccines Distributors List
Table 102. H1N1 Vaccines Customers List
Table 103. H1N1 Vaccines Market Trends
Table 104. H1N1 Vaccines Market Drivers
Table 105. H1N1 Vaccines Market Challenges
Table 106. H1N1 Vaccines Market Restraints
Table 107. Global H1N1 Vaccines Sales Forecast by Type (2023-2030) & (K Units)
Table 108. Global H1N1 Vaccines Sales Market Share Forecast by Type (2023-2030)
Table 109. Global H1N1 Vaccines Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 110. Global H1N1 Vaccines Revenue Market Share Forecast by Type (2023-2030)
Table 111. Global H1N1 Vaccines Sales Forecast by Application (2023-2030) & (K Units)
Table 112. Global H1N1 Vaccines Sales Market Share Forecast by Application (2023-2030)
Table 113. Global H1N1 Vaccines Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 114. Global H1N1 Vaccines Revenue Market Share Forecast by Application (2023-2030)
Table 115. Global H1N1 Vaccines Sales Forecast by Region (2023-2030) & (K Units)
Table 116. Global H1N1 Vaccines Sales Market Share Forecast by Region (2023-2030)
Table 117. Global H1N1 Vaccines Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 118. Global H1N1 Vaccines Revenue Market Share Forecast by Region (2023-2030)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of H1N1 Vaccines
Figure 2. Global H1N1 Vaccines Market Share by Type in 2022 & 2030
Figure 3. Intramuscular Vaccines Product Picture
Figure 4. Intranasal Vaccines Product Picture
Figure 5. Intradermal Vaccines Product Picture
Figure 6. Global H1N1 Vaccines Market Share by Application in 2022 & 2030
Figure 7. Influenza
Figure 8. Meningococcal
Figure 9. Cervical Cancer
Figure 10. Pneumococcal
Figure 11. Hepatitis
Figure 12. Measles
Figure 13. Mumps
Figure 14. Rubella
Figure 15. Others
Figure 16. Global H1N1 Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2030
Figure 17. Global H1N1 Vaccines Market Size (2018-2030) & (US$ Million)
Figure 18. Global H1N1 Vaccines Sales (2018-2030) & (K Units)
Figure 19. H1N1 Vaccines Sales Share by Manufacturers in 2022
Figure 20. Global H1N1 Vaccines Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest H1N1 Vaccines Players: Market Share by Revenue in 2022
Figure 22. H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global H1N1 Vaccines Sales Market Share by Region (2018-2023)
Figure 24. Global H1N1 Vaccines Sales Market Share by Region in 2022
Figure 25. Global H1N1 Vaccines Revenue Market Share by Region (2018-2023)
Figure 26. Global H1N1 Vaccines Revenue Market Share by Region in 2022
Figure 27. U.S. H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. Canada H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. Germany H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. France H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. U.K. H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Italy H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. Russia H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. China H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Japan H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. South Korea H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. India H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Australia H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Taiwan H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Indonesia H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Thailand H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Malaysia H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Philippines H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Vietnam H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 45. Mexico H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 46. Brazil H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 47. Argentina H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 48. Turkey H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 49. Saudi Arabia H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 50. U.A.E H1N1 Vaccines Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 51. Sales Market Share of H1N1 Vaccines by Type (2018-2023)
Figure 52. Manufacturing Cost Structure of H1N1 Vaccines
Figure 53. Manufacturing Process Analysis of H1N1 Vaccines
Figure 54. H1N1 Vaccines Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount